Koers Repros Therapeutics Inc

Aandelen

26-01-18	Repros Announces Negative Opinion From the EMA for Enclomiphene
15-12-17	Repros Therapeutics Inc.® Receives Feedback Following an Oral Explanation with the European Medicines Agency
12-12-17	REPROS THERAPEUTICS INC. Rigrodsky & Long, P.A. Announces Investigation of Buyout
12-12-17	Levi & Korsinsky, LLP Reminds Investors of an Investigation Concerning Whether the Sale of Repros Therapeutics Inc. to Allergan plc is Fair to Shareholders
12-12-17	Repros Therapeutics Inc.® Announces Acquisition by Allergan plc

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
REPROS THERAPEUTICS INC	-.--%	+0,74%	-	-	0
LONZA GROUP AG	+1,07%	-3,49%	-3,25%	+12,87%	46,35 mld.
REVOLUTION MEDICINES, INC.	+0,54%	+1,90%	+409,67%	+631,30%	40,13 mld.
BEONE MEDICINES AG	-0,30%	+4,70%	+10,20%	+67,33%	36,33 mld.
IQVIA HOLDINGS INC.	+1,00%	+1,60%	+4,35%	-8,16%	34,6 mld.
CELLTRION, INC.	+3,14%	+1,02%	+3,72%	+34,86%	26,77 mld.
ASCENDIS PHARMA A/S	+2,03%	-0,82%	-	-	16,66 mld.
MEDPACE HOLDINGS, INC.	+0,03%	+12,72%	+33,02%	+145,46%	16,91 mld.
EUROFINS SCIENTIFIC SE	+0,42%	-5,52%	+0,76%	+8,50%	13,05 mld.
ICON PUBLIC LIMITED COMPANY	-1,09%	-1,05%	-13,74%	-30,67%	13,05 mld.
Gemiddelde	+0,67%	+1,02%	+55,59%	+107,69%	27,09 mld.
Gewogen gemiddelde per kap.	+0,81%	+0,77%	+76,14%	+137,32%